BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 23, 2026
Johnson & Johnson Beats Profit Expectations, Lifts Forecast Following… Read More
© 2026 CSRXP- All Rights Reserved
Updates
THEY SAID IT! LAWMAKERS AND HEALTH CARE EXPERTS CALL FOR BIPARTISAN SOLUTIONS TO BOOST GENERIC AND BIOSIMILAR COMPETITION TO LOWER PRESCRIPTION DRUG PRICES
Apr 17, 2026
HELP Committee Hearing Puts the Spotlight on Big Pharma’s Anti-Competitive… Read More
ICYMI: NEW REPORT OUTLINES MERCK’S STRATEGY TO BLOCK COMPETITION, KEEP PRICES HIGH ON BLOCKBUSTER CANCER DRUG KEYTRUDA
Apr 15, 2026
Big Pharma Giant Engages in Product Hopping Strategy to Game the Patent… Read More
CSRxP ENCOURAGES HELP COMMITTEE TO BUILD MOMENTUM BEHIND BIPARTISAN SOLUTIONS TO LOWER PRESCRIPTION DRUG PRICES BY FOSTERING GREATER COMPETITION
Apr 15, 2026
Lawmakers Should Reject Big Pharma’s Debunked Rhetoric on Innovation… Read More
BIRDS OF A FEATHER: BIG PHARMA M&A SPLURGE BRINGS TOGETHER DRUG COMPANIES WITH SHARED TRACK RECORD OF PRICE HIKES OUTPACING INFLATION
Apr 14, 2026
Big Pharma Giants Acquire New Blockbuster Products with Existing History of… Read More
THEY SAID IT! U.S. SENATORS URGE FDA TO FURTHER CRACK DOWN ON BIG PHARMA’S DTC ADVERTISING
Apr 13, 2026
Bipartisan Letter Targets Big Pharma’s Misleading Ads That Inflate Costs And… Read More
THEY SAID IT! HHS OFFICIAL: “COMPETITION IS AN INCREDIBLY EFFECTIVE TOOL TO ADDRESS HIGH DRUG PRICES”
Mar 27, 2026
Administration Touts Positive Steps to Bring More Biosimilars to Market… Read More
DOSE OF REALITY: GSK’S BRAND NAME INHALER BAIT-AND-SWITCH INCREASED COSTS AND WORSENED HEALTH OUTCOMES
Mar 18, 2026
New Report Details Impact of Big Pharma Giant’s Strategy to Maintain… Read More
ICYMI: FDA GUIDANCE PROMOTES ACCELERATED BIOSIMILAR DEVELOPMENT AND COMPETITION
Mar 11, 2026
Boosting Biosimilar Competition and Cracking Down on Big Pharma’s Egregious… Read More
DOSE OF REALITY: HEALTH AFFAIRS SCHOLAR ANALYSIS FINDS BIG PHARMA’S PATENT ABUSE GROWING IN SCALE, KEEPING PRESCRIPTION DRUG PRICES HIGH
Mar 3, 2026
New Report Demonstrates How Brand Name Drug Companies Wield Litigation Around… Read More
CSRxP STATEMENT ON PRESIDENT TRUMP’S STATE OF THE UNION ADDRESS
Feb 24, 2026
Administration and Congress Must Enact Market-Based Solutions to Hold Big… Read More
BIG PHARMA EARNINGS WATCH: AMGEN AND BRISTOL MYERS SQUIBB
Feb 13, 2026
Big Pharma Tops Earnings Forecasts After Hiking Drug Prices, Again This month,… Read More